These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34728182)

  • 21. A retrospective cohort study on the pathology and outcomes of type 2 diabetic patients with renal involvement.
    Li M; Li CM; Ye ZC; Rao JL; Peng H; Lou TQ
    Int Urol Nephrol; 2021 Feb; 53(2):333-341. PubMed ID: 33021708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.
    Shimizu M; Furuichi K; Kitajima S; Toyama T; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Miyagawa T; Hara A; Iwata Y; Sakai N; Kitagawa K; Yoshimura M; Yokoyama H; Wada T
    BMC Nephrol; 2021 Sep; 22(1):319. PubMed ID: 34560842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
    Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
    J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When to perform renal biopsy in patients with type2 diabetes mellitus? Predictive model of non-diabetic renal disease.
    García-Martín F; González Monte E; Hernández Martínez E; Bada Boch T; Bustamante Jiménez NE; Praga Terente M
    Nefrologia (Engl Ed); 2020; 40(2):180-189. PubMed ID: 31761446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus.
    Guthoff M; Wagner R; Randrianarisoa E; Hatziagelaki E; Peter A; Häring HU; Fritsche A; Heyne N
    Sci Rep; 2017 Jan; 7():40627. PubMed ID: 28091558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis.
    Erbak Yılmaz H; Aksun S; Günay S; Elmalı F; Çekiç C
    Arab J Gastroenterol; 2023 Aug; 24(3):175-179. PubMed ID: 37045728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy.
    Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH
    Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infection.
    Outinen TK; Mäkelä S; Huttunen R; Mäenpää N; Libraty D; Vaheri A; Mustonen J; Aittoniemi J
    J Intern Med; 2014 Oct; 276(4):387-95. PubMed ID: 24717117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
    Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
    Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.
    Guo SM; Han M; Chen MX; Ning Y; Pei GC; Li YQ; Dai W; Ge SW; Deng YJ; Guo YY; Li XQ; Haller H; Xu G; Rong S
    PLoS One; 2015; 10(9):e0138718. PubMed ID: 26380984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.
    Chen J; Zhang WW; Chen KH; Lin LR; Dai HZ; Li KL; Zhang JG; Zheng LQ; Fu BQ; He YN
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F273-F281. PubMed ID: 28356293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
    Franco Palacios CR; Lieske JC; Wadei HM; Rule AD; Fervenza FC; Voskoboev N; Garovic VD; Zand L; Stegall MD; Cosio FG; Amer H
    Transplantation; 2013 Aug; 96(4):394-9. PubMed ID: 23736353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLINICOPATHOLOGIC FEATURES AND PROGNOSIS OF TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY IN DIFFERENT AGE GROUPS: MORE ATTENTION TO YOUNGER PATIENTS.
    Wang J; Zhao L; Zhang J; Wang Y; Wu Y; Han Q; Wang T; Zhang R; Grung P; Xu H; Liu F
    Endocr Pract; 2020 Jan; 26(1):51-57. PubMed ID: 31557073
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy.
    Feng Y; Zhong X; Ni HF; Wang C; Tang TT; Wang LT; Song KY; Tang RN; Liu H; Liu BC; Lv LL
    J Transl Med; 2021 Aug; 19(1):355. PubMed ID: 34404433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.